March 8, 2023
TB and Women, on International Women’s Day 2023
February 23, 2023
TB Alliance Announces David Norton as Board Chair
February 23, 2023
Fireside Chat with Bruce Carter
A conversation with outgoing Chair of the TB Alliance Board of Directors
February 20, 2023
SimpliciTB Trial Results Presented at CROI 2023
Clinical Trial for Drug-Sensitive and Drug-Resistant TB Regimen Evaluated Shorter Regimens
February 3, 2023
Qurient Co. Ltd. and TB Alliance Announce Exclusive License Agreement for Telacebec (Q203), a New Anti-Tuberculosis Agent
Landmark Agreement for New Tuberculosis Treatment
December 19, 2022
8 Things to Know about Drug-Resistant Tuberculosis
December 19, 2022
Price reduction paves the way for expanded access to highly effective multidrug-resistant tuberculosis treatment
November 16, 2022